The choice no woman wants to make

Pollak, Suzanne
October 2013
Washington Jewish Week;10/3/2013, Vol. 49 Issue 40, p1
The article reflects on the increased chances of being diagnosed with mutated BRCA1 or BRCA2 gene that can causes breast cancer or ovarian cancer in Jewish women from Ashkenazi heritage. It informs about the program titled "Hereditary Cancer: Knowledge is Power" organized at the Jewish Community Center of Greater Washington in Rockville, Maryland from October 9-16, 2013. It mentions the organization Facing Our Risk of Cancer (FORCE) that helps women to face the disease.


Related Articles

  • Competing risks analysis in mortality estimation for breast cancer patients from independent risk groups. Zhang, Shengfan; Ivy, Julie; Wilson, James; Diehl, Kathleen; Yankaskas, Bonnie // Health Care Management Science;Sep2014, Vol. 17 Issue 3, p259 

    This study quantifies breast cancer mortality in the presence of competing risks for complex patients. Breast cancer behaves differently in different patient populations, which can have significant implications for patient survival; hence these differences must be considered when making...

  • Risk Perception Among Women at Risk for Hereditary Breast and Ovarian Cancer. Pilarski, Robert // Journal of Genetic Counseling;Aug2009, Vol. 18 Issue 4, p303 

    This paper is a summation of selected history and literature on risk perception as it pertains to genetic counseling and testing, with a focus on hereditary breast and ovarian cancer, the area which has seen the greatest focus of research. Risk perception is a complex and incompletely understood...

  • Perfil sócio demográfico e possíveis fatores de risco em mulheres com câncer de mama: um retrato da amazônia. Santos da Penha, Nathalia; Batista do Nascimento, Daisy Esther; Costa Pantoja, Ana Cristina; Mesquita de Oliveira, Annie Elisandra; Ferraz Maia, Cristiane do Socorro; Soares Vieira, Ana Carolina // Revista de Ciências Farmacêuticas Básica e Aplicada;2013, Vol. 34 Issue 4, p579 

    Breast cancer is the type of cancer that most frequently affects women, worldwide and in Brazil, and its occurrence is related to exposure to various risk factors. This study analyzed a number of variables that could be risk factors for breast cancer in 18 women diagnosed with this cancer in a...

  • Mammographic Breast Density and Common Genetic Variants in Breast Cancer Risk Prediction. Lee, Charmaine Pei Ling; Choi, Hyungwon; Soo, Khee Chee; Tan, Min-Han; Chay, Wen Yee; Chia, Kee Seng; Liu, Jenny; Li, Jingmei; Hartman, Mikael // PLoS ONE;9/24/2015, Vol. 10 Issue 9, p1 

    Introduction: Known prediction models for breast cancer can potentially by improved by the addition of mammographic density and common genetic variants identified in genome-wide associations studies known to be associated with risk of the disease. We evaluated the benefit of including...

  • Passive Smoking Exposure from Partners as a Risk Factor for ER+/PR+ Double Positive Breast Cancer in Never-Smoking Chinese Urban Women: A Hospital-Based Matched Case Control Study. Tong, Jian-hua; Li, Zhi; Shi, Jing; Li, He-ming; Wang, Yan; Fu, Ling-yu; Liu, Yun-peng // PLoS ONE;May2014, Vol. 9 Issue 5, p1 

    Background: The relationship between passive smoking exposure (PSE) and breast cancer risk is of major interest. Objective: To evaluate the relationship between PSE from partners and breast cancer risk stratified by hormone-receptor (HR) status in Chinese urban women population. Design:...

  • Polymorphisms in DNA repair genes and breast cancer risk in Russian population: a case-control study. Shadrina, Alexandra; Ermolenko, Natalia; Boyarskikh, Uljana; Sinkina, Tatiana; Lazarev, Alexandr; Petrova, Valentina; Filipenko, Maxim // Clinical & Experimental Medicine;Feb2016, Vol. 16 Issue 1, p21 

    Genetic variation in DNA repair genes can alter an individual's capacity to repair damaged DNA and influence the risk of cancer. We tested seven polymorphisms in DNA repair genes XRCC1, ERCC2, XRCC3, XRCC2, EXOI and TP53 for a possible association with breast cancer risk in a sample of 672 case...

  • Fanconi anaemia, BRCA2 mutations and childhood cancer: a developmental perspective from clinical and epidemiological observations with implications for genetic counselling. Meyer, Stefan; Tischkowitz, Marc; Chandler, Kate; Gillespie, Alan; Birch, Jillian M.; Evans, D. Gareth // Journal of Medical Genetics;Feb2014, Vol. 51 Issue 2, p71 

    Fanconi anaemia (FA) is an inherited condition characterised by congenital and developmental abnormalities and a strong cancer predisposition. In around 3-5% of cases FA is caused by biallelic mutations in the BRCA2 gene. Individuals heterozygous for BRCA2 mutations have an increased risk of...

  • Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations. Brohet, Richard M.; Velthuizen, Maria E.; Hogervorst, Frans B. L.; Meijers-Heijboer, Hanne E. J.; Seynaeve, Caroline; Collée, Margriet J.; Verhoef, Senno; Ausems, Margreet G. E. M.; Hoogerbrugge, Nicoline; van Asperen, Christi J.; García, Encarna Gómez; Menko, Fred; Oosterwijk, Jan C.; Devilee, Peter; van't Veer, Laura J.; van Leeuwen, Flora E.; Easton, Douglas F.; Rookus, Matti A.; Antoniou, Antonis C.; Resource, HEBON // Journal of Medical Genetics;Feb2014, Vol. 51 Issue 2, p98 

    Background BRCA1 or BRCA2 mutations confer increased risks of breast and ovarian cancer, but risks have been found to vary across studies and populations. Methods We ascertained pedigree data of 582 BRCA1 and 176 BRCA2 families and studied the variation in breast and ovarian cancer risks using a...

  • Large BRCA1 and BRCA2 genomic rearrangements in Polish high-risk breast and ovarian cancer families. Rudnicka, Helena; Debniak, Tadeusz; Cybulski, Cezary; Huzarski, Tomasz; Gronwald, Jacek; Lubinski, Jan; Gorski, Bohdan // Molecular Biology Reports;Dec2013, Vol. 40 Issue 12, p6619 

    BRCA1 and BRCA2 are two major genes associated with familial breast and ovarian cancer susceptibility. In Poland standard BRCA gene test is usually limited to Polish founder BRCA1 mutations: 5382insC, C61G and 4153delA. To date, just a few single large genomic rearrangements (LGRs) of BRCA1 gene...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics